Anna Krug
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 2
- Multiple Myeloma Research and Treatments 2
- Hematopoietic Stem Cell Transplantation 1
-
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 3
- Co-authors
- Daniel Aaron Pollyea (6 shared papers)Craig T. Jordan (6 shared papers)Shanshan Pei (6 shared papers)Brett M. Stevens (6 shared papers)Haobin Ye (5 shared papers)Angelo D’Alessandro (5 shared papers)Courtney L. Jones (5 shared papers)Rachel Culp‐Hill (4 shared papers)
- Journals
- Cancer Cell (2 papers)Cancer Discovery (2 papers)Blood (2 papers)Cell stem cell (1 paper)Nature Cancer (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Anna Krug
9 papers receiving 1.5k citations
Anna Krug's Hit Papers
Peers
Comparison fields: 5 of 62
- Hematology 914
- Cancer Research 308
- Genetics 138
- Molecular Biology 906
- Immunology 138
Countries citing papers authored by Anna Krug
This map shows the geographic impact of Anna Krug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Krug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Krug more than expected).
Fields of papers citing papers by Anna Krug
This network shows the impact of papers produced by Anna Krug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Krug. The network helps show where Anna Krug may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Krug, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells Hit paper breakdown → | 2018 | 484 |
| 2 | Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia Hit paper breakdown → | 2020 | 400 |
| 3 | 2020 | 237 | |
| 4 | 2020 | 174 | |
| 5 | 2021 | 109 | |
| 6 | 2019 | 56 | |
| 7 | 2020 | 26 | |
| 8 | 2024 | 2 | |
| 9 | 2022 | 1 | |
| 10 | Relacje inwestorskie jako narzędzie budowania zaufania uczestników rynku kapitałowego | 2008 | 0 |
About Anna Krug
Anna Krug is a scholar working on Hematology, Molecular Biology, Biochemistry, Genetics and Cancer Research, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers), Leadership and Management in Organizations (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Leadership, Human Resources, Global Affairs (1 paper). The work is most often cited by research in Hematology (914 citations), Cancer Research (308 citations), Genetics (138 citations), Molecular Biology (906 citations) and Immunology (138 citations). Anna Krug has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Daniel Aaron Pollyea, Craig T. Jordan, Shanshan Pei, Brett M. Stevens, Haobin Ye, Angelo D’Alessandro, Courtney L. Jones, Rachel Culp‐Hill, Clayton A. Smith and James V. DeGregori. Their work appears in journals such as Cancer Cell, Cancer Discovery, Blood, Cell stem cell and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.